Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07466940) titled 'A Clinical Study to Evaluate SM17 in Healthy Participants' on March 3.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: SinoMab BioScience Ltd
Condition:
Atopic Dermatitis
Asthma
Inflammatory Bowel Disease
Intervention:
Biological: SM17
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: October 14, 2025
Target Sample Size: 30
Countries of Recruitment:
China
To know more, visit https://clinical...